Hina Arif-Tiwari1,
David Becker-Weidman2, Bobby T. Kalb1, Diego R. Martin1
1Medical
Imaging, University of Arizona, College of Medicine, Tucson, AZ, United
States; 2Radiology, Thomas Jefferson University, Philadelphia, PA,
United States
Lipid poor AA may be distinguished from malignant adrenal lesions with high specificity through combined assessment of dynamic, postcontrast 3D T1W and ssT2 sequences. Excluding metastatic HCC, there is a 100% PPV for distinguishing lipid poor adrenal adenoma from MA.